Carregant...
Halometasone 0.05% Cream in Eczematous Dermatoses
Objective: The authors aimed to document the real-life performance of halometasone 0.05% w/w cream in day-today practice through this multicenter, open-label, Phase 4 study in India. Methods: The authors enrolled 302 eligible patients either with acute or chronic eczema and treated them with halomet...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Matrix Medical Communications
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3848651/ https://ncbi.nlm.nih.gov/pubmed/24307924 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|